Piper Sandler Reiterates Overweight on Omnicell, Lowers Price Target to $45

Benzinga Newsdesk www.benzinga.com Negative 87.5%

Neg 87.5% Neu 0% Pos 0%

Piper Sandler analyst Jessica Tassan reiterates Omnicell (NASDAQ:OMCL) with a Overweight and lowers the price target from $55 to $45.